Impaired vascular function in sepsis-surviving rats mediated by oxidative stress and Rho-Kinase pathway  by de Souza, Priscila et al.




Impaired vascular function in sepsis-surviving rats mediated by oxidative
stress and Rho-Kinase pathway
Priscila de Souzaa, Karla Lorena Guaridob, Karin Scheschowitschb, Luísa Mota da Silvaa,
Maria Fernanda Wernera, Jamil Assreuyb, José Eduardo da Silva-Santosb,⁎
a Department of Pharmacology, Universidade Federal do Paraná, Curitiba, Paraná, Brazil
b Department of Pharmacology, Laboratory of Cardiovascular Biology, Universidade Federal de Santa Catarina, Florianópolis, Santa Catarina, Brazil






A B S T R A C T
We investigated long-lasting changes in endothelial and vascular function in adult rat survivors of severe sepsis
induced by cecal ligation and puncture (CLP) model. For this, male Wistar rats (200–350 g) had their cecum
punctured once (non-transﬁxing hole) with a 14-gauge needle. Performed in this way, a mortality rate around
30% was achieved in the ﬁrst 72 h. The survivors, together with age-matched control rats (not subjected to
CLP), were maintained in our holding room for 60 days (S60 group) and had the descending thoracic aorta
processed for functional, histological, biochemical or molecular analyses. Endothelium-intact aortic rings
obtained from sepsis-surviving S60 group displayed increased angiotensin II-induced contraction, accompanied
by decreased activity of the endogenous superoxide dismutase, augmented reactive oxygen species generation,
and increased levels of tyrosine nitration compared with vessels from control group. The superoxide scavengers
superoxide dismutase and tempol, and the antioxidant apocynin, were able to avoid this enhanced contractility
to angiotensin II in aortic rings from the S60 group. In addition, aortic rings from the S60 group presented
reduced sensitivity to Y-27632, a Rho-kinase (ROCK) inhibitor. Immunoblot analyses revealed augmented
RhoA and ROCK II, and high levels of phosphorylation of myosin phosphatase target subunit 1 in vessels from
S60 rats. In conclusion, aortic rings from sepsis-surviving rats display endothelial dysfunction mediated by the
increased production of reactive oxygen species, which in turn reduces the bioavailability of nitric oxide and
increases the formation of peroxynitrite, and enhances RhoA-ROCK-mediated calcium sensitization, leading to
augmented contractile responses to angiotensin II. Notably, this is the ﬁrst study demonstrating long-term
dysfunction in the vasculature of sepsis-surviving rats, which take place or remain beyond the acute septic
insult.
1. Introduction
In spite of the acute nature of sepsis, several epidemiological
investigations have revealed that the mortality rate among those
patients who survive the episode of severe sepsis or septic shock is
strikingly higher when compared with age-matched people who never
had sepsis [1,2]. For instance, a pioneering study published by Quartin
et al. (1997), disclosed that 80% of the 1505 survivors of the septic
episode evaluated in their study died in less than 8 years [3]. Although
these ﬁndings clearly indicate that a single episode of sepsis is
predictive of an increased risk of death in a few years, the physiological
and/or pathological events that occur beyond the period of sepsis
remain poorly understood. It is important to note that despite a
number of studies having conﬁrmed the decreased life expectancy
among those who survived sepsis [4–8], most of the animal studies in
this ﬁeld were conducted focusing only in the ﬁrst hours or days after
the induction of sepsis, with few exception regarding the investigation
of long-term cognitive deﬁcits, mainly involving learning and memory
impairments [9–11].
It is well known that the functionality of the cardiovascular system
is depressed by sepsis. This includes the inability of vessels to keep
their tone and development of systemic hypotension, which results in
inadequate blood perfusion and oxygenation of several tissues, and has
a major role in the dysfunction of multiple organs [12]. Interestingly, if
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on the one hand pre-existing cardiovascular diseases have been shown
to contribute to the progression to heart failure and higher mortality
rates among individuals diagnosed with septic shock [13], on the other
hand, recent clinical data revealed an increased risk of cardiovascular
diseases, including myocardial infarction and stroke, among survivors
of severe sepsis [14]. In this regard, we hypothesized that in spite of the
reestablishment of normal blood pressure, the vascular biology of
survivors from severe sepsis remains impaired for prolonged periods.
According to our knowledge, our study is one of the few evaluating
the late consequences of sepsis in a period exceeding 30 days, and the
ﬁrst to explore long-term dysfunctions in the vascular system. Here we
present an animal model of long-term endothelial and vascular
dysfunction that can be described as sequelae of the septic insult.
The results presented also reveal that NAD(P)H oxidase-derived
reactive oxygen species (ROS) and reactive nitrogen species (RNS),
as well as the RhoA/Rho-associated protein kinase (ROCK) signaling
pathway, contribute to the hyper-contractility evoked by angiotensin II
(AII) in the vasculature of sepsis-surviving rats.
2. Materials and methods
2.1. Animals and experimental model of sepsis
Two hundred male Wistar rats (3 months) supplied by
Universidade Federal do Paraná (UFPR, Curitiba, PR, Brazil) were
used in the experiments. All procedures described in this study have
been carried out in accordance with Guidelines for the Care and Use of
Laboratory Animals from U.S. National Institutes of Health [15], and
were approved by the Institutional Animal Care and Use Committee of
UFPR (authorization number 527). The protocol used in the cecal
ligation and puncture (CLP) model was followed according to Rittirsch
and coworkers [16], with minor modiﬁcations. The rats were anesthe-
tized with ketamine/xylazine (100/20 mg/kg, ip). A skin midline
incision was performed in the abdomen, the cecum was exposed and
ligated (comprising 75% of the cecum). Since the mortality rate
obtained in this model is fully dependent on the size of the needle
used and number of punctures performed in the cecum
(Supplementary Results – Fig. S1), the animals used in this study
had their cecum punctured once (non-transﬁxing hole) with a 14-gauge
needle. A small amount of stool was expelled from the puncture to
ensure leakage of the intestinal content, and the incision was closed in
layers with sutures applied in the abdominal muscle and skin. Finally,
all animals received a postoperative ﬂuid resuscitation by injecting
sterile saline solution (3 mL/100 g, s.c.) to prevent dehydration.
Performed in this way, a mortality rate around 30% was achieved in
the ﬁrst 72 h (Supplementary Results – Fig. S1, 1 hole 14 -gau-
gegroup). The survivors (n=88), together with age-matched control
(CT) rats (not subjected to CLP; n=90), were maintained in our holding
room under controlled conditions (12/12 h light-dark cycle, and
temperature of 22 ± 2 °C), with free access to chow and water for 30
days (S30 group; n=12), or 60 days (S60 group; n=76). At the selected
time-point, the animals were subjected to general anesthesia induced
by ketamine/xylazine (100/20 mg/kg, ip), and had the descending
thoracic aorta carefully removed, cleaned of connective tissue and
processed for functional, histological, biochemical or molecular ana-
lyses.
2.2. Functional study in organ baths
In these experiments the aortas were mounted in classical organ
baths for measurement of contractile force generation via isometric
transducers. The details regarding the isolation of tissue and experi-
mental design, including the addition of pharmacological tools are
detailed in the Supplementary Methods.
Fig. 1. Enhanced AII-induced vasoconstriction in the aorta of sepsis-surviving rats and involvement of AT1 receptors. The vessels were obtained from control animals (CT; age-matched
naïve rats) or sepsis-surviving rats at 60 days after the CLP (S60), as indicated in each panel. AII-induced contraction in A) endothelium-intact rat aortic rings, B) endothelium-denuded
rat aortic rings, C) endothelium-intact rat aortic rings previously incubated with L-NAME (100 μM), D) and E) endothelium-intact rat aortic rings previously incubated with vehicle or
the AT1R antagonist losartan. F) Representative images and densitometric analysis (in arbitrary units, A.U.) of levels of AT1R protein in aortas from CT and S60 groups. The results show
the mean ± SEM of preparations obtained from 6 to 8 animals per group (panels A–E), or samples from 4 diﬀerent animals per group (panel F). Statistical analyses were performed by
means of two-way analysis of variance (ANOVA) followed by Bonferroni's post-test (panels A–E) or unpaired Student t-test (panel F). * Indicates p < 0.05 compared with the respective
CT group.
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2.3. Immunoblot analyses
The protein levels of AT1 receptors, Rho-A, ROCK-I, ROCK-II, total
and phosphorylated MYPT-1 in the aorta of CT and S60 groups were
assessed by Western blot analysis, as previously detailed [17] and
presented in the Supplementary Methods.
2.4. Biochemical analyses of oxidative stress
Samples of aortas from CT and S60 groups were processed for
determination of lipid hydroperoxide (LOOH) levels [18], reduced
glutathione (GSH) contents [19], as well as for measurement of the
activity of superoxide dismutase (SOD) [20,21], catalase (CAT) [22],
and glutathione S-transferase (GST) [23]. In addition, sections of
aortas were allocated in microscope slides and loaded with dihydroethi-
dium (DHE), with or without exposure to angiotensin II (40 nM) for
assessment of reactive oxygen species generation. Diﬀerent slides were
incubated with primary antibody against nitrotyrosine followed by
secondary antibody conjugated with phycoerythrin for detection of
tyrosine nitration. The steps followed for each set of experiments are
presented in the Supplementary Methods.
2.5. Statistical analysis
The results are expressed as mean ± standard error of mean
(S.E.M.). Statistical signiﬁcance was determined using two-way analy-
sis of variance (ANOVA) followed by Bonferroni'spost-test, or Student's
t-test, when applicable. A p value less than 0.05 was considered
statistically signiﬁcant. The graphs were drawn and the statistical
analyses were performed using GraphPad Prism version 6 for Mac
(GraphPad Software, La Jolla, CA, USA).
3. Results
3.1. Standard control and experimental groups
Preliminary data revealed that at 6 h after the cecal ligation and
puncture (CLP) surgery to induce sepsis the animals (n=12) presented
piloerection, porphyrin secretion (eyes and nose) and lethargy, as well
as leukocytopenia, thrombocytopenia and granulocytosis, high levels of
blood nitrate and nitrite (an indicative of exacerbated production of
nitric oxide), hypotension, and both in vivo and in vitro refractoriness
to vasoconstrictors, conﬁrming the ability of the CLP model to induce
several aspects commonly found in severe sepsis. None of these signs
were recorded in sham-operated or in age-matched control animals
(CT groups; data not shown). Importantly, all animals that survived to
CLP were fully recovered after 5 days and remained undistinguished
from CT animals during the 60 days of follow-up, including parameters
such as body weight, water and chow consumption (Supplementary
Results – Table S1).
3.2. Increased AII-induced contraction in vessels from sepsis-
surviving rats
To explore our hypothesis that sepsis-surviving rats present long-
term changes in vascular reactivity, thoracic aortas were tested in organ
baths for development of contractile force induced by vasoactive agents
commonly used in studies of vascular biology. The aortic rings obtained
from the S60 group did not present any diﬀerence in the reactivity to
acetylcholine, sodium nitroprusside, KCl, phenylephrine and angioten-
sin I, compared with vessels from CT rats (Supplementary Results –
Fig. S2). However, the contractile eﬀect induced by cumulative con-
centrations of AII was signiﬁcantly increased in endothelium-intact
aortic rings from the S60 group (Fig. 1A). For instance, the maximal
increase in vascular tone induced by AII, reached when the ﬁnal the
concentration of 3 μM was added, varied from 0.65 ± 0.08 to 1.26 ±
0.16 g in CT and S60 groups, respectively. Similarly, the non-cumula-
tive addition of 3 μM AII increased the contractile force of aortic rings
from CT and S60 groups by 0.58 ± 0.14 and 1.22 ± 0.09 g, indicating
that the maximal eﬀects induced by cumulative concentrations of AII
was not being reduced by tachyphylaxys.
Our experiments did not reveal any diﬀerence in the vascular
reactivity between aortic rings obtained from the S30 group and its
respective CT group (Supplementary Results – Fig. S3). For this, the
next steps of this study were conducted only with animals from the S60
group.
3.3. Lack of inﬂuence of endothelium removal, and eﬀect of nitric
oxide synthase (NOS) inhibition on AII-induced contraction in aortic
rings from sepsis-surviving rats
The increased responsiveness to AII was found only in endothe-
lium-intact aortic rings (Fig. 1A), as the mechanical damage of the
endothelial layer was completely without eﬀect on AII-induced con-
traction in vessels from the S60 group (Fig. 1B). On the other hand,
incubation with the NOS inhibitor L-NAME raised the contractile
responses to AII in aortic rings from both CT and S60 groups (Fig. 1C).
3.4. Participation of angiotensin II type 1 receptor (AT1R) in the
enhanced eﬀects of AII in aortas from sepsis-surviving rats
AII-induced contraction was reduced to similar levels by losartan in
both the CT and S60 groups (Fig. 1D and E). However, the Western
blot analysis in the aortas from CT and S60 groups did not reveal any
diﬀerence in the protein levels of the AT1R (Fig. 1F).
3.5. Absence of histological changes in aortas from sepsis-surviving
rats
As shown in the Supplementary Fig. S5, there were no signals of
morphological changes, inﬂammatory cell migration, edema, hyper-
trophy, or collagen deposition in histological sections from either the
CT or S60 groups.
3.6. Impairment of endogenous antioxidant machinery in the
vasculature of sepsis-surviving rats
In spite of the lack of diﬀerences in the activity of catalase (CAT)
and glutathione S-transferase (GST), the activity of superoxide dis-
mutase (SOD) in aortic homogenates of the S60 group was decreased
by 45% in the S60 group. Furthermore, the levels of glutathione (GSH)
and lipid hydroperoxide (LOOH) were increased by 98% and 24%,
respectively, compared with the CT group (Table 1), indicating that the
endogenous antioxidant machinery was impaired in vessels from S60
group.
Table 1
Impaired antioxidant system in the aorta of sepsis-surviving rats.
Control group S60 group
Lipid hydroperoxide (µmol/mg protein) 11.2 ± 0.5 13.9 ± 1*
Reduced glutathione (µg/g of tissue) 277.2 ± 54.6 548.9 ± 107.5*
Superoxide dismutase (U/mg protein) 28.8 ± 3 15.8 ± 0.8*
Catalase (µmol/min/mg protein) 5.6 ± 0.4 4.7 ± 0.6
Glutathione S-transferase (nmol/min/mg
protein)
429.3 ± 63.6 432.6 ± 79.8
The values show the mean ± S.E.M. of 6–8 samples per group, obtained from different
animals. Statistical analyses were performed using Student's t-test. S60 group, sepsis-
surviving rats at 60 days after the CLP.
* Indicates p < 0.05 when compared with the respective control group (age-matched
naïve animals).
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3.7. Superoxide scavengers avoided AII-induced augmented
contraction in aortic rings from sepsis-surviving rats
To determine whether the imbalance between endogenous antiox-
idant and ROS production would contribute to increase the contractile
eﬀects of AII, we performed functional experiments in the presence of
exogenous superoxide scavengers and antioxidants. The incubation of
aortic rings with SOD, or tempol (a SOD mimetic agent), did not
change the contractile eﬀects of AII in vessels from CT animals, but
abolished the hyper-reactivity to AII in preparations obtained from S60
group (Fig. 2A–D). Similarly, the commonly used inhibitor of NAD(P)
H oxidases, apocynin, prevented the exacerbated responses to AII in
aortas from the S60 group, without modify AII-induced contraction in
CT vessels (Fig. 2E and F).
3.8. Augmented oxidative and nitrosative stress in aortas from
sepsis-surviving rats
Experiments using the ﬂuorescent probe dyhydroethidium (DHE)
revealed that in spite of unchanged basal levels, the generation of ROS
under stimulation by AII was augmented (up to 30%) in vessels from
the S60 group, compared with the CT group (Fig. 3A and B),
reinforcing the hypothesis of an increased oxidant status in vessels
from sepsis-surviving rats. As the superoxide anion may readily
interact with NO to form the strong RNS peroxynitrite, we evaluated
the amounts of nitrotyrosine present in aortas from the S60 group as
Fig. 2. Inhibition of the enhanced contractile eﬀects of AII in aortic rings from sepsis-surviving rats by apocynin, SOD and tempol. Aortic rings obtained from control (CT group; left
panels) or sepsis-surviving rats (S60 group; right panels) had their reactivity to AII evaluated after incubation with superoxide dismutase (SOD; A and B), tempol (C and D), or apocynin
(E and F). For comparative purposes, the contractile eﬀects of AII were measured in aortic rings from both CT and S60 groups previously incubated with vehicle (closed circles). The
results show the mean ± SEM of preparations obtained from 4 to 6 animals per group. Statistical analyses were performed by means of two-way analysis of variance (ANOVA) followed
by Bonferroni's post-test. * Indicates p < 0.05 compared with the respective vehicle-treated group.
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an indicator of exposure to peroxynitrite. Notably, aortas from the S60
group presented more than a 3-fold increase in the degree of tyrosine
nitration, compared with samples from CT animals, indicating exacer-
bated production of peroxynitrite in vessels from sepsis-surviving rats
(Fig. 3C and D).
3.9. Reduced eﬀects of the ROCK inhibitor Y-27632 on AII-induced
contraction in aortas from sepsis surviving rats
To explore a possible mechanism contributing to the AII-induced
hyper-contractility in vessels from sepsis-surviving rats, we used the
selective ROCK inhibitor Y-27632 in functional experiments. The
analyses of the relaxation induced by Y-27632 in phenylephrine-
contracted aortic rings from S60 animals revealed a parallel rightward
shift in the cumulative concentration-response curve for this agent,
with a corresponding increase in the half maximal eﬀective concentra-
tion (EC50) for relaxation from 0.43 (0.33–0.55) to 1.03 (0.76–1.40)
µM, in CT and S60 groups, respectively (Fig. 4A). Moreover, aortic
rings from CT animals had their reactivity to AII reduced by 60% after
incubation with 0.3 µM Y-27632 (Fig. 4B), but this same concentration
of ROCK inhibitor failed to do the same in vessels from the S60 group
(Fig. 4C). Importantly, 1 µM Y-27632 prevented AII-induced contrac-
tion in both the CT and S60 groups (data not shown).
3.10. Expression of Rho-A, ROCK II and phosphorylated MYPT-1 are
increased in the aorta from sepsis-surviving rats
The immunoblot data revealed a remarkable increase in the
expression of RhoA in aortas from the S60 group (Fig. 4D).
Moreover, compared with the CT group, aortas from the S60 group
presented augmented levels of ROCK II (Fig. 4F), without any change
in ROCK I (Fig. 4E), or in total MYPT-1 (Fig. 4G). The RhoA/ROCK
system is well known as a calcium-sensitization pathway due its ability
to inhibit the activity of myosin phosphatase through phosphorylation
of the myosin phosphatase target subunit 1 (MYPT-1) [24]. In
particular, our results revealed hyperphosphorylation of MYPT-1 at
Thr-855 (Fig. 4I), but not at Thr-697 (Fig. 4H), in homogenates of
aortas obtained from the S60 group.
4. Discussion
The ﬁrst important ﬁnding in our study was that despite the
recovery from the vascular dysfunction provoked by sepsis, and the
lack of detectable abnormalities at 30 days after the CLP surgery, aortic
rings from sepsis-surviving rats presented enhanced contractile re-
sponses to AII at 60 days after the septic insult. Although this data
cannot be used to state that the entire vascular system from sepsis-
surviving rats is more sensitive to AII-induced contraction, and
additional studies mainly with resistance vessels remain to be carried
out, the contractile responses evoked by AII were also augmented in
Fig. 3. Increased ROS and RNS levels in the aorta of sepsis-surviving rats. A) Representative images and B) analysis of the relative ﬂuorescence intensity (in arbitrary units, A.U.)
obtained with the ﬂuorescent dye dyhydroethidium (DHE) in aortic sections from control (CT) and sepsis-surviving rats at 60 days after the CLP (S60) under stimulation with vehicle or
angiotensin II, as indicate inside the panels. C) Representative images and D) analysis of the relative ﬂuorescence intensity (in arbitrary units, A.U.) of tyrosine nitration detected by
ﬂuorescent antibody against nitrotyrosine in aortic sections from control (CT) and sepsis-surviving rats at 60 days after the CLP (S60). The blue color in the right images represents the
nuclei stained with Hoeschst blue. The images were acquired using magniﬁcation of x40. The results show the mean ± SEM of samples obtained from 4 diﬀerent animals per group.
Statistical analysis was performed by unpaired Student's t-test. ns indicates not signiﬁcant; # Indicates p < 0.05 compared with the S60 group exposed to vehicle only; * Indicates p <
0.05 compared with the respective CT group. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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endothelium-intact carotid rings obtained from the S60 group
(Supplementary Results – Fig. S4), indicating that this hyperrespon-
siveness to AII occurs not only in aorta but also in other conductance
vessels.
The lack of changes in the eﬀects of phenylephrine, a selective
agonist of α1A-adrenoceptors, suggested that the impairment of
vascular reactivity to AII could be associated with regulatory changes
in AT1 or AT2 receptors in the vasculature. Indeed, increased expres-
sion of AT1R has been described in several cardiovascular diseases, in
both animals and humans [25], and AT2 receptors are well known for
their counter-regulatory actions against activation of the AT1 receptors
[26]. The inhibitory eﬀect of the selective antagonist losartan found in
our experiments clearly indicates that the enhanced reactivity to AII
found in aortas from the S60 group was fully dependent on the
activation of AT1R. Notably, we have not found diﬀerences in the level
of AT1R in aortas from the S60 group, compared with samples from the
CT group, a data suggesting that the enhanced AII-induced vasocon-
striction in vessels from the S60 group was not associated with an
augmented expression of these receptors, but instead it was fully
dependent on AII-evoked intracellular signaling.
Physiologically, the tone of vessels is maintained by a rigorous
balance between hormonal and paracrine factors that mediate either
vascular dilation or constriction. Among these factors, NO produced
mainly by endothelial cells through the endothelial NOS (eNOS) has
been accepted as the major regulator of vascular tone [27]. Our data
showing that endothelium removal was completely unable to change
the vascular reactivity to AII in aortic rings from the S60 group, in spite
of the well described ability of this approach to increase the vascular
reactivity to contractile agents in control preparations (as found in our
CT group), was a suggestion of impairment of the endothelial function
in the aorta from the S60 group. Interestingly, inhibition of NOS by L-
NAME raised the vascular reactivity of aortic rings from both CT and
S60 groups, indicating that the production and the role of NO in the
control of vascular tone was, at least in part, maintained in vessels from
the S60 group, a ﬁnding that may explain why acetylcholine-induced
relaxation was not impaired in these vessels (Supplementary Results –
Fig. S2A). Importantly, a number of clinical investigations have
described endothelial dysfunction and the reduction in the bioavail-
ability of NO as an important predictor of cardiovascular risk [28,29].
Several mechanisms may contribute to the reduced bioavailability
of NO in the vascular system, including reduced expression, dimeriza-
tion, or activation of the eNOS [30], and its enhanced breakdown by
increased oxidative stress [31]. However, it is very important to note
that the disrupted endothelial function found in vessels from the S60
Fig. 4. Reduced sensitivity of aortic rings from sepsis-surviving rats to the ROCK inhibitor Y-27632 and augmented levels of components of the RhoA/Rho-kinase pathway. The vessels
were obtained from control animals (CT; age-matched naïve rats) or sepsis-surviving rats at 60 days after the CLP (S60), as indicated in each panel. A) Relaxation induced by Y-27632 in
endothelium-intact aortic rings. B) and C) Angiotensin II-induced contraction in endothelium-intact aortic rings from CT and S60 groups, respectively, previously incubated with vehicle
or the ROCK inhibitor Y-27631. The results show the mean ± SEM of preparations obtained from 4 to 6 animals per group. Statistical analyses were performed by means of two-way
analysis of variance (ANOVA) followed by Bonferroni's post-test. * Indicates p < 0.05 compared with the respective vehicle-treated group; # Indicates p < 0.05 compared with CT.
Representative images and densitometric analyses of D) RhoA, E) ROCK I, F) ROCKMethods of enzymatic analysis II, G) MYPT-1, H) pMYPT-1 (at Thr697) and I) pMYPT-1 (at Thr855)
in aortas from CT and S60 groups. The results show the mean ± SEM of 4–6 samples or preparations per group, obtained from diﬀerent animals. Statistical analyses were performed by
means of two-way analysis of variance (ANOVA) followed by Bonferroni's post-test (panels A-C), or unpaired Student's t-test (panels D–I). * Indicates p < 0.05 when compared with the
respective control group.
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group was fully dependent on stimulation by angiotensin II. It is now
well established that AT1 receptors, mainly in endothelial cells, may be
coupled to the membrane-associated NAD(P)H oxidase (Nox) enzymes,
stimulating the production of superoxide in the vessels. It is interesting
to mention that several previous studies associated endothelial dys-
function and hypertension induced by AII with superoxide generation
in the vascular system [32]. Taking into account that superoxide
interacts with and inactivates NO, mainly in endothelial cells, the
normalization of AII-induced vasoconstriction in the aortic rings from
the S60 group after incubation with SOD, or the SOD mimetic tempol,
or apocynin, and the evidence of increased oxidative stress obtained
with the ﬂuorescent dye DHE in aortas stimulated by AII, the second
most important ﬁnding of our study was that aortic rings from sepsis-
surviving rats present endothelial dysfunction, characterized by the
augmented production of superoxide anion, and putative reduction in
the bioavailability of NO when stimulated by AII. Although our results
do not allow us to clearly state the molecular mechanisms involved in
this process, the reduction in the activity (or availability) of SOD found
in aorta homogenates from the S60 group may account, at least in part,
for the accumulation of superoxide in the aorta.
SOD is a major player in the endogenous antioxidant system. This
enzyme catalyzes the dismutation of the superoxide anion to hydrogen
peroxide, which in turn reacts with a number of enzymes, including
catalases, peroxiredoxins, glutathione and peroxidases, as well as
cellular thiol-containing compounds, which play a major role in the
redox control of cell function [33]. Impaired production of any ROS
and/or disruption of redox homeostasis can lead to oxidative stress,
promoting or amplifying inﬂammatory processes [34], platelet aggre-
gation [35], activity of matrix metalloproteinases [36], and the
proliferation of vascular smooth muscle [37], among others.
Although we did not explore any of these possibilities, one consequence
of oxidative stress found in the aortas of sepsis-surviving rats was the
augmented lipid peroxidation, which can induce the oxidative degrada-
tion of membrane lipids [38], as evidenced by increased levels of
LOOH. We have not explored the activity of enzymes such as
glutathione peroxidase and glutathione reductase, nor the levels of
oxidized GSH (GSSH) in our experiments, but the higher amounts of
reduced glutathione (GSH) measured in aortas of the S60 group, which
were not correlated with changes in the activity of GST, conﬁrmed the
impaired redox status and may be associated with a compensatory
mechanism to confer protection against oxidative damage in these
vessels. For instance, a number of studies have indicated that the
expression of glutamylcysteine synthetase, responsible for glutathione
synthesis, is sensitive to oxidative stress [39–41]. In spite of the lack of
changes in the vascular reactivity to angiotensin II at earlier stages
after the septic insult (i.e. 30 days after sepsis; Supplementary Results
– Fig. S3F), the onset of the changes in the markers of oxidative stress
in vessels from survivors of sepsis deserves to be investigated, since
early changes in the redox state may have a crucial role in the
development of the vascular dysfunction found at 60 days after sepsis.
The accumulation of superoxide deregulates its diﬀusion-controlled
reaction with NO, reducing the bioavailability of NO and augmenting
the generation of peroxynitrite, a highly reactive oxidizing and nitrating
agent. Increased levels of peroxynitrite in vessels over long periods
have been described as an important mechanism involved in the
development of various forms of cardiovascular diseases, including
stroke, myocardial infarction, chronic heart failure and circulatory
shock [42]. Accordingly with the increased nitration of tyrosine found
in our experiments, it is reasonable to conclude that the aortas from the
S60 group present an increased production of superoxide, which
results in the excessive suppression of endothelium-derived NO and
the accumulation of peroxynitrite. Peroxynitrite was previously asso-
ciated with a signiﬁcant increase in RhoA activity in the coronary
arteries of diabetic rats [43]. Further, peroxynitrite-mediated nitration
at Tyr-34 in RhoA after LPS challenge resulted in the 2-fold increased
activity of RhoA in human lung microvascular endothelial cells [44].
RhoA is a small G protein expressed in a wide range of cells.
Importantly, RhoA and its downstream eﬀector ROCK mediate several
eﬀects of AII [45]. After stimulation by RhoA, ROCK phosphorylates
the regulatory subunit 1 of the myosin light chain phosphatase (MYPT-
1), inhibiting this enzyme [46]. For this, the RhoA/ROCK pathway is
often described as a calcium sensitization system, and is an important
regulator of vascular tone in both health and disease [24]. The third
important point disclosed in our study was that the RhoA/ROCK
pathway was more active in vessels from the S60 group, as suggested by
the reduced sensitivity to the ROCK inhibitor Y-27632 found in our
functional experiments in organ baths, the increased protein levels of
both RhoA and ROCK II, and the augmented phosphorylated MYPT-1,
as detected by Western-blot assays. Interestingly, phosphorylation of
MYPT-1 at Thr-855 in rats, as found in the S60 group, has been
previously associated with myogenic responses mediated by RhoA/
ROCK pathway after agonist stimulation, independently of phosphor-
ylation at Thr-697 [47]. Abnormal activation of the RhoA/ROCK
pathway was previously implicated in cytoskeleton reorganization,
focal adhesion and migration of vascular smooth muscle cells during
the development of several cardiovascular diseases. We did not disclose
any evidence of histological, morphological, or inﬂammatory-asso-
ciated impairment in the aortic rings of sepsis-surviving rats from
the S60 group. However, taking into account the augmented activity of
the RhoA/ROCK pathway, the enhanced responsiveness to AII, the
ROS- and RNS-associated endothelial dysfunction described in this
study, and the putative relationship between these factors and several
cardiovascular diseases, the development of histological changes
including but not restrict to vascular remodeling in later periods after
sepsis, or in speciﬁc vascular beds, deserves further consideration.
In summary, this is the ﬁrst study describing that sepsis-surviving
rats present long-term impairment in the vascular system, including
endothelial dysfunction, which was characterized by the increased
production of superoxide and increased generation of peroxynitrite.
This oxidative and nitrosative environment may contribute to the
augmented activity of the RhoA/ROCK pathway, which in turn plays
a major role in the enhanced responsiveness to AII, among other
potentially deleterious eﬀects that remain to be investigated.
Importantly, the acute events that occur during the septic insult and
contribute for such late changes in the vascular function remain to be
characterized. Moreover, additional studies using both in vitro and in
vivo approaches, and including more prolonged periods of time, also
must be carried out to investigate the behavior of the cardiovascular
system after a septic insult.
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